News About: Pharm. Industry
Industry to seek niche markets with new natural crude drugs.
The Korea pharmaceutical industry understood that the new natural crude drug would be the most ideal item to explore a way of their survivals as a niche market which could be compatible instead of confrontation with t...
Jinyang Pharm's anti-SARS therapy is spotlighted in Southeast markets
As the outbreak of severe acute respiratory syndrome is hitting the Southeast regions, Jinyang Pharm's combination therapy of ribavirin plus steroid preparations there has been popular in the treatment of SARS and hep...
Impotence drugs in hot combatting market stage.
The competitive phase of impotence drug markets has been surfaced after completing their underground detecting works each other.
Lilly Korea is now concentrating their efforts on Cialis by recruiting more sales st...
MSD Korea President Lee Seung-woo Korea named executive director in Asia zone
According to MSD Korea, the incumbent president Lee Seung-woo is said to assume the position of executive director who will be responsible for the total strategic program in Asia but it made no comment on who will suc...
Pharmaceutical makers' total technical export revenue hovers at $500 million
Domestic pharmaceutical firms' total technical export volume amounted to about $470 million as of the end of 2002, the Korea Drug Research Association said recently.
According to tallies by the association,...
Industry trying to overcome business slump with total healthcare.
The pharmaceutical industry realized that they could never make their sales increases nor escape from the current prevailing business slump unless so called total healthcare business with functional foods and cosmetic...
Cialis sales in Europe on the steep rise.Elli Lilly launched Cialis, a new anti-impotence drug, to the European market in Feb. this year with so favorable response that the already preoccupied markets with Viagra seeme... |
Net profits during first quarter this year plunged.
Most of listed pharmaceutical companies reported net profit declines during the first quarter of this year.
According to the Yakup Press data, 20 listed drug companies sold 660.9 billion won of their sales during t...
KOSDAQ-listed pharmaceutical firms fared well in the first half
According to statistics compiled by Yakup Shinmoon, KOSDAQ-listed pharmaceutical firms whose fiscal year closes March 31st fared well in the first quarter of this year. Details:
Turnover of KOSDAQ-listed ph...
Daewoong Pharm sells one capsule package of comp. Ursa
In an attempt to cope with the inconvenience of customers and pharmacists, Daewoong Pharm said that it had already supplied to pharmacies diverse package forms of composite Ursa capsule (60 capsules, 10 capsules, and ...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
